
Bristol-Myers Squibb will not attempt to bring its new combination hepatitis C treatment to the US market given the current …
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations

